Castellani Speaks on Global Health Progress at U.S. State Department

Castellani Speaks on Global Health Progress at U.S. State Department

03.17.11 | By

PhRMA President & CEO John Castellani was one of the invited speakers today at a symposium of global health challenges hosted by the U.S. State Department.

John spoke about what America's biopharmaceutical research companies are doing to help in the fight against disease that most affect patients in the developing world and especially neglected tropical diseases.

One fact that I found particularly interesting was the finding by the G-Finder Report 2010, which found that the biopharmaceutical research sector is the third largest investor in efforts to find solutions for global health challenges behind the U.S. government and the Gates Foundation.

In fact, over the last decade, the biopharmaceutical research sector has invested over $9.2 billion in direct assistance to improve healthcare throughout the developing world.

Global Health Progress is a good place to look for more information on what the biopharmaceutical research industry is doing to help improve health in the developing world. Another good source is the International Federation of Pharmaceutical Manufacturers & Associations where they have great information on partnerships to improve health in the developing world between biopharmaceutical makers, governments and NGOs.

More On PhRMA — powered by PhRMApedia


Cost in Context